首页> 外国专利> HYBIRD CELL LINE FOR PRODUCING MONOCLONAL ANTIBODY TO A HUMAN EARLY THYMOCYTE ANTIGEN ANTIBODY METHOD OF PREPARATION OF THIS ANTIBODY DIAGNOSTIC AND THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THIS ANTIBODY

HYBIRD CELL LINE FOR PRODUCING MONOCLONAL ANTIBODY TO A HUMAN EARLY THYMOCYTE ANTIGEN ANTIBODY METHOD OF PREPARATION OF THIS ANTIBODY DIAGNOSTIC AND THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THIS ANTIBODY

机译:Hybird细胞系,用于生产单克隆抗体到人类早期胸腺细胞抗体,制备该抗体的诊断和治疗用途以及包含该抗体的药物组合物

摘要

Hybrid cell line for production of monoclonal antibody to an antigen found on approximately 10% of normal human thymocytes. The hybrid is formed by fusing splenocytes from immunized CAF1 mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
机译:用于在大约10%的正常人胸腺细胞中发现的针对抗原的单克隆抗体生产的杂交细胞系。该杂种是通过将来自免疫CAF1小鼠的脾细胞与P3X63Ag8U1骨髓瘤细胞融合而形成的。还公开了单克隆抗体的诊断和治疗用途。

著录项

  • 公开/公告号MY8600518A

    专利类型

  • 公开/公告日1986-12-31

    原文格式PDF

  • 申请/专利权人 ORTHO PHARMACEUTICAL CORPORATION;

    申请/专利号MY19860000518

  • 发明设计人 KUNG PATRICK CHUNG-SHU;GOLDSTEIN GIDEON;

    申请日1986-12-30

  • 分类号C12P1/00;C12N5/00;C12N15/00;G01N33/50;C12R1/91;

  • 国家 MY

  • 入库时间 2022-08-22 07:19:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号